Trials / Conditions / Congenital Amegakaryocytic Thrombocytopenia

Congenital Amegakaryocytic Thrombocytopenia

6 registered clinical trials studyying Congenital Amegakaryocytic Thrombocytopenia.

Status	Trial	Sponsor	Phase
Completed	Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marro NCT04965597	Fred Hutchinson Cancer Center	Phase 2
Terminated	Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Pa NCT03333486	Roswell Park Cancer Institute	Phase 2
Completed	Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem NCT01529827	Roswell Park Cancer Institute	Phase 2
Completed	Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Fai NCT00295971	University of California, San Francisco	Phase 1
Completed	Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With NCT00301834	University of California, San Francisco	Phase 2
Completed	Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young P NCT00305708	University of California, San Francisco	Phase 1 / Phase 2